Park Ha Biological Technology Co., Ltd. (PHH)
NASDAQ: PHH · Real-Time Price · USD
12.79
+0.96 (8.11%)
At close: Mar 28, 2025, 4:00 PM
12.56
-0.23 (-1.80%)
After-hours: Mar 28, 2025, 7:32 PM EDT

Company Description

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China.

The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand.

It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People’s Republic of China.

Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology logo
Country China
Founded 2016
IPO Date Dec 27, 2024
Industry Household & Personal Products
Sector Consumer Staples
Employees 17
CEO Xiaoqiu Zhang

Contact Details

Address:
901 & 901-2, Building C
Wuxi, 214000
China
Phone 86 40 0012 7562
Website parkha.cn

Stock Details

Ticker Symbol PHH
Exchange NASDAQ
Fiscal Year November - October
Reporting Currency USD
IPO Price $4.00
CIK Code 0001986247
CUSIP Number 693320103
ISIN Number US6933202029
SIC Code 2840

Key Executives

Name Position
Xiaoqiu Zhang Chief Executive Officer and Chairman of the Board
Xiaoyan Zhu Chief Financial Officer
Xinyu Li Chief Technology Officer and Product Manager

Latest SEC Filings

Date Type Title
Mar 3, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 24, 2025 20-F Annual and transition report of foreign private issuers
Jan 24, 2025 6-K Report of foreign issuer
Jan 7, 2025 6-K Report of foreign issuer
Dec 30, 2024 6-K Report of foreign issuer
Dec 27, 2024 424B4 Prospectus
Dec 26, 2024 CERT Certification by an exchange approving securities for listing
Dec 26, 2024 8-A12B Registration of securities
Dec 20, 2024 EFFECT Notice of Effectiveness
Dec 20, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers